Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · IEX Real-Time Price · USD
1.560
+0.040 (2.63%)
Apr 26, 2024, 1:15 PM EDT - Market open
Atossa Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Atossa Therapeutics stock have an average target of 4.50, with a low estimate of 4.00 and a high estimate of 5.00. The average target predicts an increase of 188.46% from the current stock price of 1.56.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ATOS stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +156.41% | Apr 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +156.41% | Apr 2, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +156.41% | Feb 12, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $5 | Buy | Initiates | $5 | +220.51% | Sep 8, 2023 |
Maxim Group | Maxim Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Dec 18, 2019 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.27
from -0.24
EPS Next Year
-0.30
from -0.27
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 171.6M | 661.7M | 1.2B |
Avg | n/a | n/a | 95.6M | 455.1M | 732.0M |
Low | n/a | n/a | n/a | 256.9M | 327.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 592.4% | 154.0% |
Avg | - | - | - | 376.2% | 60.9% |
Low | - | - | - | 168.8% | -28.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.25 | -0.27 | 0.69 | 3.01 | 5.45 |
Avg | -0.27 | -0.30 | 0.23 | 2.10 | 3.49 |
Low | -0.30 | -0.34 | -0.27 | 1.22 | 1.62 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 1,184.5% | 160.0% |
Avg | - | - | - | 793.5% | 66.4% |
Low | - | - | - | 418.0% | -22.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.